Edition:
India

People: Pacira Biosciences Inc (PCRX.OQ)

PCRX.OQ on NASDAQ Stock Exchange Global Select Market

43.73USD
17 May 2019
Change (% chg)

$-0.70 (-1.58%)
Prev Close
$44.43
Open
$44.33
Day's High
$44.57
Day's Low
$43.55
Volume
188,345
Avg. Vol
186,009
52-wk High
$54.92
52-wk Low
$30.00

Reinhart, Charles 

Mr. Charles A. Reinhart, III., is Chief Financial Officer of the Company. He served as our Chief Financial Officer since May 2016. Prior to joining Pacira, he was the Chief Financial Officer at Covis Pharmaceuticals, Inc., a specialty pharmaceutical company, from September 2014 to October 2015. From September 2011 to August 2014, he served as Executive Vice President and Chief Financial Officer of Archimedes Pharma Ltd., a specialty pharmaceutical company. Mr. Reinhart also served as Senior Vice President and Chief Financial Officer of PharmAthene, Inc., a biodefense company engaged in the development of next generation medical countermeasures against biological and chemical threats, from 2009 to 2011. In addition, Mr. Reinhart has previously held senior financial roles at Millennium Pharmaceuticals, Inc., Cephalon, Inc. and several early-stage life sciences companies. Mr. Reinhart earned his Bachelor of Science degree from Lehigh University and his MBA from the Wharton School of the University of Pennsylvania. He is also a CPA.

Basic Compensation

Total Annual Compensation, USD 555,894
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 763,041
Fiscal Year Total, USD 1,318,940

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Stack

4,718,920

Charles Reinhart

1,318,940

Robert Weiland

1,924,580

Kristen Williams

1,527,720

Richard Scranton

1,686,600

Mark Froimson

197,923
As Of  31 Dec 2017